SVB’s Megan Scheffel on Bio-Hope, the 2026 Landscape, and Longevity

Join us from San Francisco, as we sit down with Megan Scheffel, Head of Healthcare and Life Science at SVB. Megan breaks down the current state of healthcare investment, moving beyond the noise to focus on deal-making quality. We cover the rising bar for entrepreneurs, the convergence of longevity and consumer wellness, and AI's impact on patient data. Don't forget to subscribe to our Substack: https://substack.com/@digitalhealthroundtable